---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-014894"
form_type: "8-K"
ticker: "MLTX"
cik: "0001821586"
company_name: "MoonLake Immunotherapeutics"
filed_at: "2022-03-24T23:59:59+00:00"
generated_at: "2026-06-26T18:44:54.061284+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Helix Acquisition Corp. receives $150,000 working capital loan from affiliate Cormorant Asset Management

## Summary
- Cormorant Asset Management LP, an affiliate of Helix officers, loaned $150,000 for working capital.
- Loan is non-interest bearing, non-convertible, payable upon consummation of a business combination.
- If no business combination occurs, the loan is forgiven except for funds available outside trust account.
- Helix is pursuing a business combination with MoonLake Immunotherapeutics AG as previously disclosed.

## SEC filing metadata
- accession: 0001213900-22-014894
- form_type: 8-K
- ticker: MLTX
- cik: 0001821586
- company_name: MoonLake Immunotherapeutics
- filed_at: 2022-03-24T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821586/000121390022014894/0001213900-22-014894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821586/000121390022014894/ea157366-8k425_helix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-014894
- JSON: https://secwatch.observer/filing/0001213900-22-014894.json
- Plain text: https://secwatch.observer/filing/0001213900-22-014894.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.